Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice
ABSTRACT Protective antigen (PA) is a component of anthrax toxin that can elicit toxin-neutralizing antibody responses. PA is also the major antigen in the current vaccine to prevent anthrax, but stability problems with recombinant proteins have complicated the development of new vaccines containing...
Guardado en:
Autores principales: | Fabiana Freire Mendes de Oliveira, Sireesha Mamillapalli, Srinivas Gonti, Robert N. Brey, Han Li, Jarad Schiffer, Arturo Casadevall, James G. Bann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5b08a3442284ba9b28cd6995fad9269 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Using CAST-test to investigate human specific hypersensitivity to the anthrax pathogen
por: D. G. Ponomarenko, et al.
Publicado: (2020) -
COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
por: N. I. Mikshis, et al.
Publicado: (2018) -
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
por: Jean-Nicolas Tournier, et al.
Publicado: (2019) -
Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen
por: Anita Verma, et al.
Publicado: (2018) -
Detecting specific memory t and b cells in volunteers annually revaccinated with live anthrax vaccine
por: V. V. Firstova, et al.
Publicado: (2019)